Suppr超能文献

脊髓性肌萎缩症(Kugelberg-Welander 病)3 型的临床特征。

Clinical features of spinal muscular atrophy (SMA) type 3 (Kugelberg-Welander disease).

机构信息

Centre de référence PACA Réunion Rhône Alpes, La Timone University Hospital, Aix-Marseille University, Marseille, France; Aix Marseille University, INSERM, GMGF, Marseille, France; FILNEMUS.

FILNEMUS; Unité Neuromusculaire de l'Enfant, Service de Neurologie et Réanimation Pédiatrique, Hôpital Raymond Poincaré (GH APHP Université Paris Saclay), Garches, France; UMR 1179 Handicap neuromusculaire : Physiopathologie, Biothérapie et Pharmacologie appliquées (END-ICAP) - UMR U1179 (INSERM/UVSQ); Centre de Référence Nord-Est-Ile de France.

出版信息

Arch Pediatr. 2020 Dec;27(7S):7S23-7S28. doi: 10.1016/S0929-693X(20)30273-6.

Abstract

Spinal muscular atrophy type 3 (SMA3), also called Kugelberg-Welander SMA, typically presents with muscle fatigue, slowly progressive weakness and atrophy of lower limbs once they have already acquired independent ambulation. Visceral involvement frequent in type 1 and 2 subtypes is rare in SMA3. Hypotonia, hyperlaxity and absent osteo-tendinous reflexes are typical features. By definition, standing or walking without support is achieved but the vast majority of SMA3 patients lose ambulation with time. Lifespan is normal. In some classifications, an additional subtype is included in the mild end of the spectrum, namely spinal muscular atrophy type 4 (SMA4). In this rare subtype, symptoms begin in adulthood; patients remain ambulatory at least until the fifth decade and have a normal respiratory function. Molecular genetic testing is the gold standard tool for diagnosis of SMA. However, diagnosis in a child affected with SMA3 is often challenging because clinical presentation mimics a muscular dystrophy. Electrodiagnostic studies and muscle biopsy are useful tools for demonstrating the presence of denervation but sometimes may not show meaningful differences to help distinguish between SMA and myopathy. Recent specific therapies show promising results before severe neuronal degeneration and motor dysfunction is installed. Therefore, high suspicion should be maintained and genetic analysis performed early in the diagnostic process when facing patients with symmetric and prominent proximal weakness, especially if they present progressive motor impairment. © 2020 French Society of Pediatrics. Published by Elsevier Masson SAS. All rights reserved.

摘要

脊髓性肌萎缩症 3 型(SMA3),也称为 Kugelberg-Welander SMA,通常表现为肌肉疲劳,下肢一旦获得独立行走能力,就会出现进行性无力和萎缩。1 型和 2 型亚型中常见的内脏受累在 SMA3 中很少见。低张力、高弛缓性和缺乏骨腱反射是其典型特征。根据定义,无需支撑即可站立或行走,但绝大多数 SMA3 患者会随着时间的推移而丧失行走能力。预期寿命正常。在某些分类中,在轻度范围内还包括另一个亚型,即脊髓性肌萎缩症 4 型(SMA4)。在这种罕见亚型中,症状始于成年期;患者至少在第五个十年仍保持行走能力,并且呼吸功能正常。分子遗传学检测是 SMA 诊断的金标准工具。然而,SMA3 患儿的诊断通常具有挑战性,因为临床表现类似于肌肉营养不良。电诊断研究和肌肉活检是用于证明失神经支配存在的有用工具,但有时可能无法显示有意义的差异,以帮助区分 SMA 和肌病。最近的特定疗法在严重神经元变性和运动功能障碍发生之前显示出有希望的结果。因此,当面对对称性和突出的近端无力的患者,尤其是当他们出现进行性运动障碍时,应在诊断过程中尽早保持高度怀疑并进行基因分析。© 2020 法国儿科学会。由 Elsevier Masson SAS 出版。保留所有权利。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验